InsidersTradesSigma
Follow the Aarti Drugs Limited stock price and the full insider trade history of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Aarti Drugs Limited has logged 67 public disclosures. Market capitalisation: €37.7bn. The latest transaction was reported on 1 April 2022 (Purchase). Among the most active insiders: Safechem Enterprises Private Limited. Every trade is accessible without an account.
67
Insider Decl.
n/a
Thresholds
€2m
16 ops.
Buy Volume
€8m
51 ops.
Sell Volume
8Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,139 of 29,064 companies
56.2
score / 100
Value52
Quality60
FCF yld2.1%
Earn yld5.2%
EV/EBITDA13.9x
ROE13%
Gross mgn37%
Net mgn7.6%
Debt/EBITDA1.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 April 2022
Declarations67 total
50,000 shares@ ₹440.73322.0% of flowEquity SharesSEBI:772990de212fbe437710799e3934274cb217caf4
53,500 shares@ ₹437.210834.9% of flowEquity SharesSEBI:7ebe6f289a05c28eb6e8501faf6fa394e23439f6
25,000 shares@ ₹440.77939.3% of flowEquity SharesSEBI:747147572648e5e25866cf3fc68dd6efdb9fa581
164,500 shares@ ₹438.130443.6% of flowEquity SharesSEBI:3a9fe497324dac3c2285044272b150405bdf912a
14,000 shares@ ₹440.780316.9% of flowEquity SharesSEBI:705cb443842637d2a2db1fe008dae568c5d04138
11,000 shares@ ₹440.780213.3% of flowEquity SharesSEBI:4c7b82e7d5ad6bb2bba5c445d591797c0c9b31d6
120,000 shares@ ₹440.536264.7% of flowEquity SharesSEBI:4cb306523b3cff167265c8eaccd8fb3d6fd2bf08
70,000 shares@ ₹438.945746.0% of flowEquity SharesSEBI:4dd9d6ec3cd7435e359970ce740b30cd8c75106c
180,615 shares@ ₹439.28248.2% of flowEquity SharesSEBI:9e317954615d4f72aad39c2c6b33b859a0370625
609 shares@ ₹459.35336.8% of flowEquity SharesSEBI:291c302e44702c60108378a3b14559eb6e4281b3
500 shares@ ₹520.98223.7% of flowEquity SharesSEBI:628de7709512da35f476ccd9d68b904cdfbb417b
20 shares@ ₹520.601.0% of flowEquity SharesSEBI:3206cff2e73608a9d0375a3fed090c3190f2a56c
500 shares@ ₹459.70821.0% of flowEquity SharesSEBI:eed19423223a3c4a224e31e9f0dab6e1b1a38dc8
500 shares@ ₹517.70623.6% of flowEquity SharesSEBI:a1d92dbd4a5f7f0bd032964a1312b71fbddf2ef0
8,600 shares@ ₹503.07954.2% of flowEquity SharesSEBI:b00f8633b13ba29b8481f45487a317d3cfbf87e8
10,000 shares@ ₹524.06265.2% of flowEquity SharesSEBI:3e15f0aadcb9df236aa025e38d215cf3f70ecc06
71,258 shares@ ₹524.543837.5% of flowEquity SharesSEBI:ff9bd60328c1d7a36c7c8315373282d9ca146315
13,120 shares@ ₹526.43486.9% of flowEquity SharesSEBI:d15ece23fe7275bb06d4145c4ad33b62f4bde008
8,705 shares@ ₹522.20644.5% of flowEquity SharesSEBI:be1f323b539b4719e2257bdf50cb32b5ca21cc5e
45,000 shares@ ₹523.128423.5% of flowEquity SharesSEBI:f86e303f1bce743f0148e37e7c58c9aecb569798
1,917 shares@ ₹522.91181.0% of flowEquity SharesSEBI:70713a810f0014cfb0ba8d519edd770551804385
200 shares@ ₹517.5750.1% of flowEquity SharesSEBI:3c10af7cc70cfd376b05420835f7e57129416b71
10,741 shares@ ₹512.44265.4% of flowEquity SharesSEBI:280e403ce2e39363ac5a4224f3f94a251f92548c
19,200 shares@ ₹519.54989.9% of flowEquity SharesSEBI:d97b94d555595295656c643f997bec9d945c325f
19,647 shares@ ₹605.08811.7% of flowEquity SharesSEBI:25e8608ef38e5ffab2db757188b904240293fbc5
25 of 67 declarations
关于 Aarti Drugs Limited
Aarti Drugs Limited 是一家印度公司，从事药品制造。该公司在孟买证券交易所上市。